These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2444743)

  • 1. [Fibrinogen degradation products in the diagnosis of pancreatitis].
    Degtiareva II; Varetskaia TV; Irodenko NA; Gaĭsenko AV
    Lab Delo; 1987; (8):576-8. PubMed ID: 2444743
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrin-fibrinogen degradation products in the blood plasma in complicated peptic ulcer and pancreatitis].
    Degtiareva II; Varetskaia TV; Gaĭsenko AV
    Vrach Delo; 1986 Dec; (12):46-51. PubMed ID: 3825071
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory diagnosis of pancreatitis and pancreatic cancer].
    Degtiareva II; Gaĭsenko AV; Putseva NM
    Vrach Delo; 1989 Jul; (7):42-4. PubMed ID: 2800494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function in experimentally induced pancreatitis in the dog.
    Jacobs RM; Murtaugh RJ; Fertel RH
    Thromb Haemost; 1986 Apr; 55(2):197-200. PubMed ID: 3087002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic significance of soluble fibrin monomer complexes in exacerbated chronic recurrent pancreatitis].
    Gubergrits NB; Monogarova NE; Shtoda LA; Kuryshko OA; Borisenko LS; Prokopenko NI; Klimova LV; Tishchenko TB; Siniachenko TIu; Samokhin RS
    Klin Lab Diagn; 1993; (5):54-6. PubMed ID: 7994547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen related antigens in acute pancreatitis.
    Schmidt A; Svend-Hansen H; Gormsen J
    Acta Chir Scand; 1976; 142(4):327-8. PubMed ID: 961320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
    Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen and fibrin degradation products in hemorrhagic fever and renal syndrome].
    Mogila TV
    Klin Med (Mosk); 1980 May; 58(5):57-60. PubMed ID: 6103976
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical value of studying fibrinogen degradation products in patients with ischemic heart disease].
    Ikonnikova EI; Katkova NB; Filippova SB
    Klin Med (Mosk); 1989 May; 67(5):35-6. PubMed ID: 2770207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrin/fibrinogen degradation products in the diagnosis of pulmonary thromboembolism].
    Ena IaM; Drannik GN; Konopleva LF
    Ter Arkh; 1985; 57(4):143-6. PubMed ID: 3892752
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of ischemic preconditioning on blood coagulation, fibrinolytic activity and pancreatic repair in the course of caerulein-induced acute pancreatitis in rats.
    Warzecha Z; Dembiński A; Ceranowicz P; Dembiński M; Cieszkowski J; Kuśnierz-Cabala B; Naskalski JW; Jaworek J; Konturek SJ; Pawlik WW; Tomaszewska R
    J Physiol Pharmacol; 2007 Jun; 58(2):303-19. PubMed ID: 17622699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical evaluation of new methods for studying fibrin degradation products].
    Prisco D
    Recenti Prog Med; 1989 May; 80(5):263-7. PubMed ID: 2669062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
    Izquierdo R; Sandberg L; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz R
    Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of plasma fibrinogen and fibrin degradation products (FDP) in 100 normal persons and 32 cases of acute cerebrovascular disease (author's transl)].
    Wang GX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Feb; 15(1):8-10. PubMed ID: 7094732
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinogen degradation products in fresh frozen plasma. Possible contribution to immunosuppression.
    Donnell CA; Daniel SJ; Ferrara JJ
    Am Surg; 1989 Aug; 55(8):505-7. PubMed ID: 2764399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.